Innovative business development in the Lithuanian capital
Vilnius City Innovation Industrial Park is the first and only industrial park in the capital of Lithuania, dedicated exclusively to the development of innovative business.
24 ha VCIIP territory is surrounded by national forests and already has a fully developed infrastructure. It is dedicated to Lithuanian and foreign companies that want to build research centres, laboratories or factories, as well as to business and science collaboration; nearby are some of the best universities in Lithuania, as well as main science centres.
In 2015, VCIIP was granted the status of a national importance economic project.
The obvious reasons to apply
Strategical location and great access
VCIIP is situated in Vilnius city, 30 minutes from the old town, the railway and bus stations, and the international airport. Three public transport stops – „Inovacijų pramonės parkas”, „Miškadvario” and „Vismaliukai” – are located in VCIIP. Although city life is really close by, the area is conveniently situated away from the street noise, surrounded by national forests.
The industrial park already has a developed infrastructure, from engineering networks to communications. All you have to do is apply and settle down.
Partnership oriented community
VCIIP was created exclusively for innovative companies that are operating in the seven areas of smart specialisation. It encourages partnership and clustering between its customers in order to take full advantage of the VCIIP community’s benefits.
The merge of science and business
VCIIP is part of the Integrated Science, Studies and Business Valley “Sauletekis” program. Nearby are two of the best Lithuanian universities and their campuses, three science centres, two science and technology parks, as well as excellent conditions for R&D infrastructure development and human resource management.
From startup to investor
VCIIP is open to companies of all sizes: from successful global companies to start-ups.
Status of national importance. No infrastructure charge
In 2015 VCIIP was granted the status of economic project of national importance that is strengthening the Lithuanian innovation system. Therefore, infrastructure development charge is not applied to the investors establishing at VCIIP.
VCIIP has been in operation since August, 2018.
Already reached results
New job openings
Technology Development Centre
By the end of 2024 a specialized Technology Development Center will be built at VCIIP, offering unique laboratory facilities specialized for the life sciences.
It is expected that life sciences companies will be located in the premises of the Technology Development Center, also – open access centers will operate here, the infrastructure and services of which will be available not only to VCIIP TDC residents, but also to other innovative companies.
Life Sciences Digital Innovation Hub (LS DIH Lithuania) Cluster is a platform for business-research partnership, dedicated to fostering digital innovation in the life sciences, bringing together research, business and public sector institutions and organizations.
Industrial Park Plan
- Subleased lands
- Operator of VCIIP
- VCIIP operator‘s Science and Business Incubator (until the end of 2022)
- Land for long-term sublease
- State forest / Public areas
- Planned streets
- Forests / Residential areas
- Reserved lands
Customers and partners’ comments
„The world is undergoing rapid developments, technological changes and an increasing pace of life. People encounter much stress and tension, which affect their emotional environment and physical condition. A healthy diet, which nowadays is hardly imagined without food supplements, is one of the major means to stay healthy and active. So racing to satisfy the daily needs of a modern human being, we keep studying the composition of contemporary food supplements and their functional elements to offer innovative solutions. That’s why we are planning to built a modern research laboratory and food supplement plant in the VCIIP territory, that will allow us to expand the range of provided products and services.”
„Most life sciences companies face similar challenges as they grow: first and foremost, the R&D and production infrastructure meeting GMP and GLP standards. In recent years, “CMB medicina” together with partners, have been carrying out R&D and production activities in the field of health technologies and biotechnologies quite intensively, therefore the need for infrastructure capacity has increased, and the possibility of concentrating activities in one place in Vilnius seemed appropriate. Therefore, in order to make better use of networking and synergy opportunities for faster development of “CMB medicina” and other companies in the sector, we chose VCIIP.”
„We have never had any doubts about the development of “CMB medicina” in Vilnius. And the choice to plan the development at VCIIP was determined by several important factors: first of all – the developed transport infrastructure and possibility to establish relatively quickly, as well as the strong core of biotechnology companies already established at VCIIP and the neighbourhood of Vilnius University and Vilnius Tech. These are important conditions that, with the development of the company’s R&D and production infrastructure, will enable the growth of both the company and the cluster of advanced therapy medicinal products and other health technologies and biotechnologies research coordinated by “CMB medicina”.”
„To continue offering Lithuanian and foreign families a world-class education with the infrastructure that meets its needs, we have planned the development of our new campus in Vilnius City Innovation Industrial Park. We have chosen VCIIP not only because of its special location surrounded by nature, but also because of the strong scientific and business community that is emerging in the innovation industrial park, with which we expect strong synergies. We employ the latest technology to enhance children’s learning experience and therefore this is an extraordinary opportunity to integrate experiential education into the learning process and to give students a chance to observe closely how scientific discoveries and innovations are born.”
„The Stem Cell Research Centre has reached the point for development. We chose a place for it in Vilnius, because the largest biotechnology competencies in Lithuania are concentrated here. For us, Vilnius is a strategic place for development due to employees, logistics and interaction with other companies in our group. We chose Vilnius City Innovation Industrial Park because of the convenient territory for business development and important communications. In addition, a unique concentration of life sciences companies and research institutions is forming in this area, with which we expect high synergy. This will be a great place to work for our existing and new employees. We have already envisaged opportunities for further development of the company – we have left room for the second stage of the company’s development. When the company will need larger biotechnology production facilities, we hope to establish a 15,000 m2 biotechnology plant here in the future.”
„The ability to establish and adapt infrastructure to our needs comes rarely, especially in such a convenient location. We see the proximity of creative companies and research institutions in the park as an opportunity to strengthen business-business and science-business synergies, which will help to implement complex projects more efficiently. No less important reason – we believe in Vilnius as a city where the highest-level professionals would like to live and create, we believe in the vision and mission of the Park. Therefore, the decision to settle at VCIIP was very simple.”
“Our decision to settle at VCIIP is based on several reasons – it is a convenient location with developed infrastructure, rapidly growing VCIIP life sciences community, and of course – the value proposition itself, which allows us to plan the rapid development of the company. In preparation for the expansion of the production of immunological diagnostic tests and their components, we are going to set up a factory and laboratory to develop new products at VCIIP by the end of 2023. It’s an important move which will help us to grow the company’s scientific and innovative potential in the future.”
“The VCIIP management team is highly oriented to life sciences sector growth and has put significant effort into accommodating our requirements and helping us grow.”
„Our main goal is to expand our business in the high-tech field, which requires highly qualified professionals and large-scale research as well as collaboration with research institutions or private companies in the biotechnology sector. Therefore, the opportunity to set up in Vilnius City Innovation Industrial Park proved to be attractive not only because of its convenient location and well-developed infrastructure, but also because of the strong life sciences companies that are developing there.”
“We have chosen VCIIP because of its amazing location — it gave us the opportunity to develop next to innovative modern companies, thus improving positions by attracting potential investors and commercial partners. Plus, nearby is Vilnius Gediminas Technical University.”
Vilnius City Innovation Industrial Park is celebrating its 5th birthday
In April 2018, the municipality of Vilnius established Vilnius City Innovation Industrial Park and in August appointed Northtown Vilnius as its operator.
5 years after the establishment of the Park, the attracted investments already exceed 73 million euros, 20 companies and 6 clusters are located in the territory, more than 500 high added value generating new job openings have been created, and a business incubator established.
The Minister of Economy and Finance Aušrinė Armonaitė visited Vilnius City Innovation Industrial Park
The Minister of Economy and Finance Aušrinė Armonaitė and her team visited Vilnius City Innovation Industrial Park.
During the visit, the vision and development of the Vilnius City Innovation Industrial Park, the establishment of investors and their activities at VCIIP were discussed. Guests also visited “Poliprojektas” and observed tests in their new-generation automatic fire extinguishing systems research laboratory.
Northtown Vilnius has become a member of LithuaniaBIO
The operator of the Vilnius City Innovation Industrial Park (VCIIP) Northtown Vilnius has become a member of the association LithuaniaBIO.
LithuaniaBIO – the association of Lithuanian biotechnologists established in 2003, today uniting more than 40 companies and institutions operating in the field of life sciences and biotechnology. The association promotes biotechnology and its wider application in the Lithuanian economy in solving global challenges of environmental protection and quality of life.
Northtown Vilnius signed a loan agreement for the construction of the VCIIP Technology Development Centre
The Operator of the Vilnius City Innovation Industrial Park (VCIIP) Northtown Vilnius signed an agreement with the Public Investment Development Agency regarding a 9,500,000 Eur loan for the construction of the VCIIP Technology Development Centre. The planned building will be adapted for scientific research and applied activities. Most of the building’s area will be occupied by specialised life sciences laboratories, and office premises will be established in the remaining part of the building.
The British School of Vilnius held a groundbreaking ceremony and is starting the construction of new school campus
On the 24th of November, 2022, The British School of Vilnius held a groundbreaking ceremony with stakeholders from the school and community and buried a time capsule, which marks the beginning of the construction of new school site at Vilnius City Innovation Industrial Park. The new campus will open in September 2023, ready for the start of the new academic year and will house 4,000 sq.m. building with state-of-the-art classrooms and facilities, swimming pool, indoor and outdoor sports areas.
Domus Naturae is starting its establishment in Vilnius City Innovation Industrial Park
Another biotechnology company – Domus Naturae, operating in the field of development, testing, production, packaging and quality assurance of food supplements – is starting its establishment in the Vilnius City Innovation Industrial Park. Domus naturae plans to establish a modern food supplement factory with an innovative research laboratory, which will allow expanding the range of currently provided products and services. The construction of food supplement plant with laboratory and administrative premises at VCIIP territory will begin in the second half of 2023.
The British School of Vilnius has presented the project for the new school campus
The British School of Vilnius hosted a new campus launch event on the 13th of May at the Grand Hotel Kempinski for its parent community, partners and many other guests, where it has presented a project for its new state of the art campus to be located at VCIIP. The British School of Vilnius has already started establishment in the Vilnius City Innovation Industrial Park and the campus will be built at VCIIP by September 2023.
CMB Medicina, developing advanced therapy medicines, plans its establishment in VCIIP
Another biotechnology company, “CMB Medicina”, is starting its establishment in Vilnius City Innovation Industrial Park, which carries out activities in the fields of tissue bank, development of advanced therapy medicinal products, and health technology research. Company plans to establish at VCIIP by 2025. Investments in CMB Medicina’s R&D and production infrastructure in line with good manufacturing and laboratory practice are expected to reach more than Eur 5 million.
BaltCap Infrastructure Fund will invest EUR 6 million into private school project in Lithuania
BaltCap Infrastructure Fund (BInF) will finance EUR 6 million development of a private school in Vilnius. The school will be built in Vilnius City Innovation Industrial Park and will be operated by The British School of Vilnius (BSV). The school will be designed by 2L architects and developed via a special purpose company BSV Development.